Trial Profile
PhaseIIa, Open Label, Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs SB (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 08 Mar 2011 New trial record